Clinical Trials List
2024-09-01 - 2027-04-30
Others
Recruiting4
ICD-10C91.10
Chronic lymphocytic leukemia of B-cell type not having achieved remission
ICD-10C91.12
Chronic lymphocytic leukemia of B-cell type in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9204.10
Chronic lymphoid leukemia, without mention of remission
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Huai-Hsuan Huang 無
- Wen-Chien Chou 無
- - - 無
- - - 無
- Chien-Chin Lin 無
- Chieh-Lung Cheng 無
- 林明恩 無
- MING YAO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tung-Liang Lin 無
- 高小雯 無
- 蘇羿囷 無
- HSUAN JEN SHIH 無
- Hung Chang 無
- 洪玉馨 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin 無
- 陳珈妤 無
- Ming-Yu Lien 無
- 鄭富銘 無
- Wei-Ching Lin 無
- 王幸婷 無
- Chi-Ching Chen 無
- Ching Yun Hsieh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
120 participants
